igus has given its micro cable carriers a facelift. Neat design features, such as a new double-stop dog system, make the latest E2 Micro chain even sturdier and quieter than its predecessors. The E2 Micro range is made up of small one or two-part cable carriers, designed especially for restricted spaces.
Parallel to the launch of the 4th generation Intel Core processors, Kontron announces its support of this new microarchitecture on a broad range of long-term available systems, boards and modules. Four intelligent platforms with improved processing and graphics performance as well as energy efficiency are available for evaluation with immediate effect.
The Optoelectronics Company has launched another innovative and cost-effective range of laser diode modules. With a diameter of only 11 mm, the modules are ergonomically designed with a small form factor for integration into a wide range of applications...
The new DELOLUX 202 / 400 LED curing lamp is based on the proven DELOLUX 20 / 400 but offers a longer irradiation line. The innovative optical system of DELOLUX 202 / 400 generates an extremely even irradiation area with intensities of more than 200 mW/cm². This is a key precondition for process-reliable adhesive curing.
Aaron Updegrove, Marketing Manager for Saint-Gobain Performance Plastics, Healthcare Markets, responded to questions regarding the use of materials in medical device design and manufacturing. He was included in the staff written article, “Materials Impact Medical Device Design Trends.” Following are all of the responses he provided.
The use of lasers in the development of medical devices through to their actual usage in the devices themselves has been a steadily growing trend. The capabilities and functionality they offer to both design engineers as well as healthcare professionals is varied and beneficial. This article looks at the advantages lasers offer in the development of medical devices.
Catheter-related bloodstream infections (CRBSIs), needlestick (sharps) injuries and exposure to potentially deadly blood borne pathogens continue to be major areas of concern for healthcare workers throughout the U.S. "We are committed to addressing these issues by providing a robust portfolio of safety-engineered IV therapy devices that offer patient protection against infection and optimum safety in the workplace," said Tom Sutton.
Suffolk (UK) based Creative Medical Research (CMR) is giving medical device manufacturers the chance to ask questions of 150 EU and US-based Diabetes Nurses through its latest Omnibus Survey. The survey has already attracted a number of the major medical device manufacturers keen to understand the concerns and thoughts of the Healthcare Professionals who focus on Diabetes and use their technologies every day.
Researchers at Weill Cornell Medical College have uncovered a mechanism that guides the exquisite wiring of neural circuits in a developing brain -- gaining unprecedented insight into the faulty circuits that may lead to brain disorders ranging from autism to mental retardation.
St. Jude Medical, Inc., a global medical device company, and privately-held Spinal Modulation, Inc., today announced that they have entered into a series of agreements under which St. Jude Medical made a $40 million equity investment in Spinal Modulation, a company that has developed an innovative neuromodulation therapy that provides a new pain management option for patients with chronic, intractable pain.
Three out of 20 flexible gastrointestinal (GI) endoscopes used for screening were found to harbor unacceptable levels of "bio dirt" – cells and matter from a patient's body that could pose potential infection risk -- according to a study of endoscopes used at five hospitals across the U.S.
The average 5-year survival for colorectal cancer is less than 10% if metastasis occurs, but can reach 90% if detected early. A new non-invasive test has been developed that measures methylation of the SDC2 gene in tissues and blood sera. This test detected 87% of all stages of colorectal cancer cases (sensitivity) without significant difference between early and advanced stages.
New research has found that routine screening using a non-invasive test that analyzes fetal DNA in a pregnant woman's blood can accurately detect Down's syndrome and other genetic fetal abnormalities in the first trimester. Published early online in Ultrasound in Obstetrics & Gynecology, the results suggest that the test is superior to currently available screening strategies and could reshape standards in prenatal testing.
Today, two scientists from Cold Spring Harbor Laboratory (CSHL) publish a mathematical method of simplifying and interpreting genome data bearing evidence of mutations, such as those that characterize specific cancers. Not only is the technique highly accurate; it has immediate utility in efforts to parse tumor cells, in order to determine a patient's prognosis and the best approach to treatment.
Alzheimer's, Schizophrenia, and Autism Now Can Be Studied with Mature Brain Cells Reprogrammed from Skin CellsJune 7, 2013 10:10 am | by Penn State University | News | Comments
Difficult-to-study diseases such as Alzheimer's, schizophrenia, and autism now can be probed more safely and effectively thanks to an innovative new method for obtaining mature brain cells called neurons from reprogrammed skin cells.